(Q42519791)

1 November 2017

title

CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept (English)

1 reference

1 November 2017

Campanati A

1

1 reference

1 November 2017

Goteri G

2

1 reference

1 November 2017

Simonetti O

3

1 reference

1 November 2017

Ganzetti G

4

1 reference

1 November 2017

Giuliodori K

5

1 reference

1 November 2017

Stramazzotti D

6

1 reference

1 November 2017

Morichetti D

7

1 reference

1 November 2017

Bernardini ML

8

1 reference

1 November 2017

Mannello B

9

1 reference

1 November 2017

Fabris G

10

1 reference

1 November 2017

Offidani A

11

1 reference

1 November 2017

language of work or name

English

0 references

publication date

4 October 2007

1 reference

British Journal of Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

157

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

1155-1160

1 reference

Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Molecular cloning of a novel CC chemokine, interleukin-11 receptor alpha-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Chemokines and the tissue-specific migration of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

CCL27-CCR10 interactions regulate T cell-mediated skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2007.08200.X

10.1111/J.1365-2133.2007.08200.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference